Similar articles

• Neuropharmacological studies on hydergine.

  Depoortere H, Loew DM, Vigouret JM. Depoortere H, et al. Triangle. 1975;14(2):73-9. Triangle. 1975. PMID: 812222 No abstract available.
• Pharmacological aspects of dihydrogenated ergot alkaloids in experimental brain research.

  Meier-Ruge W, Emmenegger H, Enz A, Gygax P, Iwangoff P, Wiernsperger N. Meier-Ruge W, et al. Pharmacology. 1978;16 Suppl 1:45-62. doi: 10.1159/000136808. Pharmacology. 1978. PMID: 205890 No abstract available.
• [Role of adrenergic mechanisms in pharmacological actions on the cerebral circulation].

  Mirzoian RS. Mirzoian RS. Vestn Akad Med Nauk SSSR. 1973;28(12):14-7. Vestn Akad Med Nauk SSSR. 1973. PMID: 4150722 Russian. No abstract available.
• Ergoloid mesylates for senile dementias: unanswered questions.

  Hollister LE, Yesavage J. Hollister LE, et al. Ann Intern Med. 1984 Jun;100(6):894-8. doi: 10.7326/0003-4819-100-6-894. Ann Intern Med. 1984. PMID: 6372566 Review.
• Some notes on the pathophysiology of cerebral sclerosis.

  [No authors listed] [No authors listed] Triangle. 1968;8(8):334-42. Triangle. 1968. PMID: 4975406 Review. No abstract available.